GABRIELA LOPEZ: Open Payments
NPI 1689193377 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 23 payments from 9 companies in 2025. Trend: 2023 $409 · 2024 $610 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| Alkermes, Inc. | 5 | $82 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Boston Scientific Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: CAPLYTA, INGREZZA, ARISTADA, Auvelity, UZEDY, SPRAVATO, LATITUDE Communicator Power Supply, MOUNJARO.
Industry payments across TX — which companies pay providers there.
